Miliary osteosarcomatosis with associated hypocalcemia.
We report the case of a patient with a rare miliary variant of osteosarcoma associated with symptomatic hypocalcemia and review the literature regarding the pathogenesis of multifocal osteosarcoma, treatment options, and the associated hypocalcemia.
Chap
L I
LI
Division of Hematology/Oncology, UCLA Medical Center, USA.
Mirra
J
J
Ippolito
V
V
Rentschler
R
R
Rosen
P
P
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005100:Expectorants / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology*; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000556:secondary; D015080:Mesna / Q000008:administration & dosage; D012516:Osteosarcoma / Q000150:complications* / Q000556:secondary
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D005100:Expectorants; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D015080:Mesna; D002945:Cisplatin; D007069:Ifosfamide